ADALIMUMAB-AFZB for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 37 adverse event reports in the FDA FAERS database where ADALIMUMAB-AFZB was used for Psoriasis.
Most Reported Side Effects for ADALIMUMAB-AFZB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 748 | 35.8% | 30 | 129 |
| Condition aggravated | 533 | 25.5% | 9 | 107 |
| Drug ineffective | 254 | 12.2% | 7 | 46 |
| Fatigue | 231 | 11.1% | 8 | 50 |
| Arthralgia | 190 | 9.1% | 2 | 32 |
| Pain | 170 | 8.1% | 7 | 30 |
| Injection site pain | 159 | 7.6% | 0 | 13 |
| Drug dose omission by device | 116 | 5.6% | 1 | 9 |
| Nausea | 115 | 5.5% | 3 | 20 |
| Headache | 113 | 5.4% | 1 | 27 |
| Inappropriate schedule of product administration | 110 | 5.3% | 3 | 28 |
| Malaise | 109 | 5.2% | 5 | 31 |
| Abdominal pain | 107 | 5.1% | 2 | 32 |
| Diarrhoea | 102 | 4.9% | 2 | 27 |
| Therapeutic product effect incomplete | 93 | 4.5% | 1 | 21 |
Other Indications for ADALIMUMAB-AFZB
Crohn's disease (913)
Rheumatoid arthritis (337)
Hidradenitis (190)
Colitis ulcerative (166)
Ankylosing spondylitis (153)
Psoriatic arthropathy (146)
Uveitis (41)
Juvenile idiopathic arthritis (38)
Product used for unknown indication (18)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)